ArticleJB & JS open access
Effects of Mecobalamin on the Prevention of Complex Regional Pain Syndrome Type 1 Following Foot Ankle Surgery: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Article in JB & JS open access. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mecobalamin has been proposed to improve the outcomes of Foot and Ankle patients with complex regional pain syndrome type 1 (CRPS-1). The primary outcome was to evaluate the effects of mecobalamin on the event rate of CRPS-1 after foot ankle surgery. The secondary outcomes were to compare the visual analog scale (VAS) and functional outcomes of both groups. Methods: The study recruited 440 patients. Operative foot and ankle patients were randomized into control (220 patients) and Mecobalamin groups (220 patients). Patients were assessed for CRPS-1 using the Budapest criteria for a follow-up period of 12 months. Preoperative and postoperative foot and ankle ability measure, Short Form 36, and VAS were compared. Results: Analysis included 432 patients. CRPS-1 occurred in 4 patients (1.8%) in the mecobalamin group compared with 20 patients (9.3%) in the placebo group. After adjustment using multivariable regression, mecobalamin was associated with a significantly lower risk of CRPS-1, with the risk difference of -8.1% (95% confidence interval: -12.4 to -3.8; p < 0.001) compared with placebo. Postoperative pain and functional outcomes also favored mecobalamin. The reduction in VAS score from preoperation to postoperation was significantly greater in the mecobalamin group, with an adjusted mean difference of -0.49 (95% confidence interval: -0.8 to -0.2; p = 0.001) at the 1-year follow-up. Conclusion: Prophylactic mecobalamin significantly lowered the occurrence of CRPS-1 in foot ankle surgery. Level of Evidence: Level I. See Instructions for Authors for a complete description of levels of evidence.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.